EUVIMEDEUVIMED entdecken
Crossref

Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes

Kazuki Sumiya, Hiroto Izumi, Kazuo Sakurai iD

ACS Applied Bio Materials · 2023

DOI: 10.1021/acsabm.2c00963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2023. Verfasst von Kazuki Sumiya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Kitakyushu, 1-1 Hibikino, Wakamatsu-ku, Kitakyushu, Fukuoka808-0135, Japan. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, MicroRNAs, Neoplasms, Oligodeoxyribonucleotides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Kitakyushu Innovative Human Resource and Regional Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For the induction of antigen-specific immune responses, adjuvants as well as antigens are essential. CpG-ODN is a potent agonist of toll-like receptor 9 (TLR9) and is known as an adjuvant to induce cellular immune responses. We previously developed a therapeutic oligonucleotide delivery system based on the formation of a complex between schizophyllan (SPG), a kind of β-1,3-glucan, and poly(dA), which actively delivered CpG-ODN to antigen-presenting cells (APCs) in the draining lymph nodes and induced antigen-specific immune responses. However, unfortunately, the signaling pathway of TLR9 is negatively regulated by an intracellular protein called suppressor of cytokine signaling-1 (SOCS-1), which suppresses the adjuvant effect of CpG-ODN. To solve this, we focused on microRNA-155 (miR-155), which regulates innate and autoimmune processes by targeting SOCS-1. In this study, we proposed a strategy of combining miR-155 and CpG-ODN, each complexed with SPG (denoted as SPG/miR-155 and SPG/CpG, respectively), to induce a more potent immune response. As a result, we showed that the efficient delivery of miR-155 to APCs by a complex form could induce much more potent cellular immune responses than SPG/CpG alone. Furthermore, the mice treated with the combination of SPG/miR-155 and SPG/CpG showed a long delay in tumor growth occurrence and improved survival after tumor inoculation. These results indicate the possibility of therapeutic strategies for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adjuvants, ImmunologicMicroRNAsNeoplasmsOligodeoxyribonucleotidesSuppressor of Cytokine Signaling 1 ProteinAnimalsMiceImmunizationSizofiranToll-Like Receptor 9

Stichwörter der Autor:innen

CpG-ODNactive-targeting deliveryantigen-presenting cellsdectin-1miR-155schizophyllan

Substanzen

Adjuvants, ImmunologicMicroRNAsMirn155 microRNA, mouseSizofiranToll-Like Receptor 9CPG-oligonucleotideOligodeoxyribonucleotidesSOCS1 protein, humanSuppressor of Cytokine Signaling 1 Protein

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Kitakyushu, 1-1 Hibikino, Wakamatsu-ku, Kitakyushu, Fukuoka808-0135, Japan.
  • Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, 1-1 Isegaoka, Yahatanishi-ku, Kitakyushu, Fukuoka807-8555, Japan.

ORCID-Profile: Kazuo Sakurai

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Kitakyushu Innovative Human Resource and Regional Development Program

Zitieren

APA

Sumiya, K., Izumi, H., & Sakurai, K. (2023). Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.2c00963

Vancouver

Sumiya K, Izumi H, Sakurai K. Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes. ACS Applied Bio Materials. 2023. doi:10.1021/acsabm.2c00963

BibTeX
@article{Sumiya2023,
  author = {Sumiya, Kazuki and Izumi, Hiroto and Sakurai, Kazuo},
  title = {Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes},
  journal = {ACS Applied Bio Materials},
  year = {2023},
  doi = {10.1021/acsabm.2c00963}
}
Kostenlos starten →